Your browser doesn't support javascript.
loading
High-sucrose diets contribute to brain angiopathy with impaired glucose uptake and psychosis-related higher brain dysfunctions in mice.
Hirai, Shinobu; Miwa, Hideki; Tanaka, Tomoko; Toriumi, Kazuya; Kunii, Yasuto; Shimbo, Hiroko; Sakamoto, Takuya; Hino, Mizuki; Izumi, Ryuta; Nagaoka, Atsuko; Yabe, Hirooki; Nakamachi, Tomoya; Shioda, Seiji; Dan, Takashi; Miyata, Toshio; Nishito, Yasumasa; Suzuki, Kazuhiro; Miyashita, Mitsuhiro; Tomoda, Toshifumi; Hikida, Takatoshi; Horiuchi, Junjiro; Itokawa, Masanari; Arai, Makoto; Okado, Haruo.
Afiliação
  • Hirai S; Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Miwa H; Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Tanaka T; Molecular Neuropsychopharmacology Section, Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo 187-8553, Japan.
  • Toriumi K; Department of Basic Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Kunii Y; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Shimbo H; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.
  • Sakamoto T; Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Hino M; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.
  • Izumi R; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.
  • Nagaoka A; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.
  • Yabe H; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.
  • Nakamachi T; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.
  • Shioda S; Laboratory of Regulatory Biology, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.
  • Dan T; Department of Clinical Pharmacy, Shonan University of Medical Sciences, Yokohama 244-0806, Japan.
  • Miyata T; Division of Molecular Medicine and Therapy, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan.
  • Nishito Y; Division of Molecular Medicine and Therapy, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan.
  • Suzuki K; Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Miyashita M; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Tomoda T; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Hikida T; Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, University of Toronto, Toronto, ON M5T 1R8, Canada.
  • Horiuchi J; Laboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan.
  • Itokawa M; Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Arai M; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
  • Okado H; Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
Sci Adv ; 7(46): eabl6077, 2021 Nov 12.
Article em En | MEDLINE | ID: mdl-34757783
ABSTRACT
Metabolic dysfunction is thought to contribute to the severity of psychiatric disorders; however, it has been unclear whether current high­simple sugar diets contribute to pathogenesis of these diseases. Here, we demonstrate that a high-sucrose diet during adolescence induces psychosis-related behavioral endophenotypes, including hyperactivity, poor working memory, impaired sensory gating, and disrupted interneuron function in mice deficient for glyoxalase-1 (GLO1), an enzyme involved in detoxification of sucrose metabolites. Furthermore, the high-sucrose diet induced microcapillary impairments and reduced brain glucose uptake in brains of Glo1-deficient mice. Aspirin protected against this angiopathy, enhancing brain glucose uptake and preventing abnormal behavioral phenotypes. Similar vascular damage to our model mice was found in the brains of randomly collected schizophrenia and bipolar disorder patients, suggesting that psychiatric disorders are associated with angiopathy in the brain caused by various environmental stresses, including metabolic stress.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Sci Adv Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Sci Adv Ano de publicação: 2021 Tipo de documento: Article